Mitchell H. Finer, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 15,000 shares at $155.89 ($2.3M) on 2015-05-15, disclosed to the SEC on 2015-05-19.
Scheduled sale ($2.3M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $153.04 | 4,849 | $742K | 32.1% |
| 2 | $153.84 | 3,815 | $587K | 25.4% |
| 3 | $155.02 | 3,829 | $594K | 25.6% |
| 4 | $155.89 | 1,707 | $266K | 11.5% |
| 5 | $157.24 | 343 | $54K | 2.3% |
| 6 | $158.19 | 342 |
| $54K |
| 2.3% |
| 7 | $159.26 | 115 | $18K | 0.8% |
| Total | $154.33 avg | 15,000 | $2.3M | 100% |
| Filing → |
| BLUE | SELL | 2015-05-06 | $2.0M | — | Filing → |
| BLUE | SELL | 2015-04-22 | $1.9M | — | Filing → |
| BLUE | SELL | 2015-04-08 | $1.8M | — | Filing → |